← Back to Search

Behavioral Intervention

Arm 1: Intervention for Insomnia

Phase < 1
Waitlist Available
Led By Chelsey R Wilks, PhD
Research Sponsored by University of Missouri, St. Louis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
clinical insomnia (defined by scoring ≥ 15 on the insomnia severity index)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

The goal of this research is to establish a proof of concept for optimizing and evaluating a personalized SMS intervention based for individuals with chronic sleep problems.

Eligible Conditions
  • Insomnia
  • Sleep Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Insomnia Severity Index
Secondary outcome measures
System Usability Scale
Other outcome measures
Difficulties in Emotion Regulation Scale
Flinders Fatigue Scale
PROMIS: Sleep related impairment
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Arm 1: InterventionExperimental Treatment1 Intervention
Participants (N=50) who endorse insomnia will be followed for 8 weeks. All participants will be asked to download a separate app to passively monitor sleep that will inform the personalized messages. Participants will also be asked to respond to daily prompts in order to validate the passive sleep data. The study includes two phases: (1) a training and validation phase and (2) an intervention phase. During phase 1, participants' sleep habits and other behaviors will be monitored for two weeks in order to validate and optimize the SMS personalized sleep intervention (PSI). In phase 2, participants will be transitioned to the intervention phase of the study.

Find a Location

Who is running the clinical trial?

University of Missouri, St. LouisLead Sponsor
14 Previous Clinical Trials
2,609 Total Patients Enrolled
Chelsey R Wilks, PhDPrincipal InvestigatorUniversity of Missouri, St. Louis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~15 spots leftby Apr 2025